ಟ್ವೀಟ್ಗಳು
- ಟ್ವೀಟ್ಗಳು
- ಟ್ವೀಟ್ಗಳು & ಪ್ರತಿಕ್ರಿಯೆಗಳು
- ಮಾಧ್ಯಮ
@cancerassassin1 ತಡೆಹಿಡಿಯಲಾಗಿದೆ
ನೀವು ಖಚಿತವಾಗಿಯೂ ಈ ಟ್ವೀಟ್ಗಳನ್ನು ನೋಡಲು ಬಯಸುವಿರಾ? ಟ್ವೀಟ್ಗಳನ್ನು ನೋಡುವುದು @cancerassassin1 ಅವರನ್ನು ತಡೆತೆರವುಗೊಳಿಸುವುದಿಲ್ಲ.
-
ಪಿನ್ ಮಾಡಿದ ಟ್ವೀಟ್
Primer on using Snapchat in oncology and cancer research by
@cancerassassin1#ASCO16#cancerresearch http://www.slideshare.net/cancerassassin1/primer-on-using-snapchat-in-oncology-and-cancer-research?ref=http://www.slideshare.net/cancerassassin1/slideshelf … via@SlideShare -
Paper writing 101. #41: Talking up your results.pic.twitter.com/wtPIbGulRl
-
Does Minneapolis have a problem retaining professionals of color?http://bit.ly/2jerQHH
-
"GEA is notoriously heterogeneous;should additional samples be assessed/how many for HER2 status? There are no data” http://cancerdiscovery.aacrjournals.org/content/7/1/OF1
-
A new set of consensus guidelines for properly evaluating HER2
#biomarkers in Gastroesophageal Cancers -@AACR http://cancerdiscovery.aacrjournals.org/content/7/1/OF1 -
Influenza virus exploits tunneling nanotubes for cell-to-cell spread. - PubMed - NCBI https://www.ncbi.nlm.nih.gov/pubmed/28059146
-
Emil Lou, MD, PhD ಹಿಂಬಾಲಿಸಿದ್ದಾರೆ DoD SBIR/STTR, Nature Biomed. Eng. ಮತ್ತು SBIR/STTR Program
-
@dodsbir
The DoD SBIR/STTR programs fund $1.1 billion annually in R&D projects at small technology companies that serve a DoD need and have commercial applications.
-
@natBME
News from the editors of Nature Biomedical Engineering, a journal for researchers, engineers and clinicians interested in human health. Launching in Jan 2017
-
-
FDA Approves Rucaparib for BRCA-Positive Ovarian Cancer https://www.cancer.gov/news-events/cancer-currents-blog/2017/fda-rucaparib-ovarian#.WHUBjozNWxw.twitter …
#gyncsm -
article in
@TIME: Why you don't have to exercise every dayhttp://ti.me/2ivS87A -
.
@CNNMoney article on first@Apple#iPhone prototype. As with any great product or idea, have to start somewhere.http://cnnmon.ie/2iYqPTW -
Committees are a death sentence for creativity because people are very adept at saying what’s wrong with an idea versus saying let’s try!
-
Happy to distribute latest issue of
@AACR@CancerTodayMag in the Masonic Cancer Clinic - check out the latest issue online for articles.pic.twitter.com/WKlUvxNv5O
-
What's cancer staging? Stage refers to the extent of cancer, such as how large the tumor is, and if it has spread: https://www.cancer.gov/about-cancer/diagnosis-staging/staging …pic.twitter.com/LT7UzrjSmm
-
Check out our paper on use of
@AmCollSurgeons#NSQIP surgical calculator in gyn onc#MIS. https://authors.elsevier.com/a/1UHbB_ZKbj2-oQ …@gyncsm@UMNGynOncology -
.
@TheScientistLLC article features NCATS and its work to repurpose existing drugs for new diseases. http://bit.ly/2iVAxFG pic.twitter.com/q8gb6pQ68M
-
.
@AACR releases first set of Project GENIE data (http://go.nature.com/2iTN11H ) We wrote about the project & its goals: http://go.nature.com/2iTSuW0 pic.twitter.com/H3b0XoMf4i
-
Don't forget: The
@LillyOCC art exhibit featuring work from#cancer community is on display through Jan. 31 at our#ClinicsAndSurgeryCenter!pic.twitter.com/0ShPOCBcWo
-
No. 23 on
@nytimes list of "52 Places to Go in 2017":#Minneapolis#Minnesota - Painting a Midwestern city purple.http://nyti.ms/2j4ypvz -
Revamping and revising how we view, differentiate, and eventually treat molecular subtypes of esophageal cancer: http://www.nature.com/nature/journal/vaop/ncurrent/full/nature20805.html …
-
Editorial in
@JOP_ASCO via@HopkinsMedicine oncology: How to Avoid Late Chemotherapy - factors to consider http://ascopubs.org/doi/abs/10.1200/JOP.2016.017137#.WG1Et9YPzGo.twitter …
ಲೋಡಿಂಗ್ ಸಮಯ ಸ್ವಲ್ಪ ತೆಗೆದುಕೊಳ್ಳುತ್ತಿರುವಂತೆನಿಸುತ್ತದೆ.
Twitter ಸಾಮರ್ಥ್ಯ ಮೀರಿರಬಹುದು ಅಥವಾ ಕ್ಷಣಿಕವಾದ ತೊಂದರೆಯನ್ನು ಅನುಭವಿಸುತ್ತಿರಬಹುದು. ಮತ್ತೆ ಪ್ರಯತ್ನಿಸಿ ಅಥವಾ ಹೆಚ್ಚಿನ ಮಾಹಿತಿಗೆ Twitter ಸ್ಥಿತಿಗೆ ಭೇಟಿ ನೀಡಿ.
Emil Lou, MD, PhD
Academia Obscura
MPR News
Barbara Corcoran
National Cancer Inst
Charles Sawyers
Deanna Teoh, M.D.
NCATS
Nature Medicine
MHealth